Search clinical trials for: Ixazomib (MLN9708)
Total 164 results
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedFollicular LymphomaUnited States, United Kingdom, Belgium, Canada
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaActive, not recruitingMultiple Myeloma | Autologous Stem Cell TransplantUnited States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more
-
TakedaTerminatedLupus NephritisUnited States, France, United Kingdom, Germany, Spain, Russian Federation, Italy
-
Emory UniversityTakedaCompleted
-
Mehdi HamadaniCompletedAllogeneic Hematopoietic Stem Cell TransplantationUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnPrecursor Cell Lymphoblastic Leukemia-lymphomaSpain, United States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and Refractory Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyTerminated
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, T-CellUnited States
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
Northside Hospital, Inc.Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Acute Leukemia | Myelodysplastic Syndrome | Lymphomas | Chronic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
Steven E. CoutreNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium...Active, not recruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyCompleted
-
National Cancer Institute (NCI)CompletedRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAdvanced CancersUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnNeoplasms | LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
Mayo ClinicTakedaCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterActive, not recruitingPlasma Cell Myeloma | Transplant-Related CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingWaldenstrom Macroglobulinemia | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedBreast CancerUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Advanced Solid TumorsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Hematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
-
National Cancer Institute (NCI)WithdrawnMultiple Myeloma
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Jason ValentCompletedMultiple Myeloma | Kahler Disease | Myelomatosis | Plasma-Cell MyelomaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.Completed
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium... and other collaboratorsActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany
-
ICOS-Texas BiotechnologyICOS Corporation; Texas Biotechnology CorporationUnknownPulmonary HypertensionUnited States, Canada
-
University Hospital, CaenRecruiting
-
Joseph TuscanoTakeda; CelgeneActive, not recruiting